Chest
New Serum Indicator of Interstitial Pneumonitis Activity: Sialylated Carbohydrate Antigen KL-6
Section snippets
Clinical Subjects
The clinical sample for this study consisted of 77 patients with interstitial pneumonitis, 21 with alveolar pneumonia, 15 with chronic bronchitis, nine with bronchial asthma, ten with emphysema, five with bronchiectasis, 21 with pulmonary tuberculosis, and ten with diffuse panbronchiolitis. The control groups consisted of 86 men and 74 women, ranging in age from 25 to 63 years, all of whom were in good health. The interstitial pneumonitis group included patients with six different types of
Distribution of KL-6 Antigens in Interstitial Pneumonitis and Normal Lung Tissues
The immunoperoxidase-labeled KL-6 antibody reacted strongly in normal lung tissues with type 2 pneumocytes and respiratory bronchiolar epithelial cells. The reaction was weak with basal cells of the terminal bronchiolar epithelium, a small number of middle layer cells of the bronchial epithelium and serous cells of the bronchial gland. The KL-6 antibody did not react with type 1 pneumocytes, goblet cells or mucous cells of the bronchial gland. The distribution of KL-6 antigens was different
DISCUSSION
At the present time, there are few diagnostic procedures which are of practical value in the evaluation of the clinical activity of patients with IIP.9 Open lung biopsy is traumatic and may result in complications such as pneumothorax or acute exacerbation of IIP. The use of 67Ga-citrate scintigrams is possible only at hospitals which have facilities for employing radioisotopes. Furthermore, frequent 67Ga scintigrams are not advised in order to avoid excess radiation exposure of the patient.
ACKNOWLEDGMENTS
The authors gratefully acknowledge the excellent technical assistance of Kyoko Ozaki, Yoshiko Watanabe, Yoko Mizunoe and Tomoko Hokao. We also wish to thank Professor Shoji Tokuoka, the Second Department of Pathology, Hiroshima University School of Medicine, for providing tissue specimens. Sera were provided by Dr. Masao Kuwabara, Hiroshima Prefectural Hospital; Dr. Hiroshi Fukuda, Mizushima Kyodo Hospital; Dr. Hiroya Egawa, Asa City Hospital; Dr. Mikio Fujita, Yoshijima Hospital; and Dr.
REFERENCES (16)
- et al.
Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis: a structure-function clinical study.
Chest
(1983) Definition and classification of interstitial pneumonias in human pathology.
Prog Resp Res
(1975)- et al.
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.
Thorax
(1980) - et al.
Clinical status and prognosis of interstitial pulmonary diseases: investigation of 500 cases in Japan.
- et al.
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.
Thorax
(1980) - et al.
Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis.
Am Rev Respir Dis
(1983) - et al.
- et al.
Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies KL-3 and KL-6 against lung adenocarcinoma.
Japan J Clin Oncol
(1988)
Cited by (444)
Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols
2023, Disease-a-MonthRole of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis
2022, Respiratory Investigation
The Radiation Effects Research Foundation (formerly the Atomic Bomb Casualty Commission) was established in April 1975 as a private, nonprofit Japanese foundation, supported equally by the Government of Japan, through the Ministry of Health and Welfare, and the Government of the United States, through the National Academy of Sciences under contract with the U.S. Department of Energy.
Manuscript received August 8; revision accepted November 24.